Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30011728HIVENSG00000139631.20protein_codingCSADNoNo51380Q86V02
Q9Y600
TVIS30075213HIVENSG00000139631.20protein_codingCSADNoNo51380Q86V02
Q9Y600
TVIS30032959HIVENSG00000139631.20protein_codingCSADNoNo51380Q86V02
Q9Y600
TCGA Plot Options
Drug Information
GeneCSAD
DrugBank IDDB00114
Drug NamePyridoxal phosphate
Target IDBE0000079
UniProt IDQ9Y600
Regulation Typecofactor
PubMed IDs15070923
CitationsSkoldberg F, Rorsman F, Perheentupa J, Landin-Olsson M, Husebye ES, Gustafsson J, Kampe O: Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate-dependent enzyme, in endocrine autoimmune disease. J Clin Endocrinol Metab. 2004 Apr;89(4):1636-40.
GroupsApproved; Investigational; Nutraceutical
Direct ClassificationPyridoxals and derivatives
SMILESCC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
PathwaysHistidinemia; 3-Methylglutaconic Aciduria Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); beta-Ketothiolase Deficiency; Tyrosine Metabolism; Disulfiram Action Pathway; Hyperprolinemia Type II; Glutamate Metabolism; Argininosuccinic Aciduria; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; Porphyrin Metabolism; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Taurine and Hypotaurine Metabolism; Catecholamine Biosynthesis; Glycine and Serine Metabolism; Carnitine Synthesis; Tyrosinemia Type 3 (TYRO3); Selenoamino Acid Metabolism; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; Starch and Sucrose Metabolism; Globoid Cell Leukodystrophy; Ammonia Recycling
PharmGKBPA164749650
ChEMBLCHEMBL82202